BERKSHIRE HATHAWAY INC

BRK-B

Berkshire Hathaway Inc., together with its subsidiaries, engages in the insurance, freight rail transportation, and utility businesses. The company provides property, casualty, life, accident, and health insurance and reinsurance; operates railroad systems in North America; generates, transmits, stores, and distributes electricity from natural gas, coal, wind, solar, hydroelectric, nuclear, and...

Country: United StatesPrice: $755570.00Market Cap: $1.08T

Company Profile

Industry: Insurance
SIC Sector: Insurance Carriers
Size: Mega Cap($1.08T)
Revenue: $371.4B+0.0% YoY
Net Income: $67.0B-24.8% YoY

Financial Snapshot

Operating Margin14.3%
Return on Equity9.3%
Debt / Equity--
Current Ratio--

Similar Companies

UNHUNITEDHEALTH GROUP INC
$360.6B
PGRPROGRESSIVE CORP/OH/
$121.9B
ELVElevance Health, Inc.
$86.8B
CICigna Group
$74.7B

Company Financials

Annual data (10-K) · Last 5 years

MetricFY 2025FY 2024FY 2023FY 2022FY 2021
Market Cap$1.1T--------
Revenue$371.4B$371.4B↑2%$364.5B↑21%$302.0B↑9%$276.2B
Operating Income$53.0B↓5%$55.7B↑29%$43.3B↑22%$35.5B↑10%$32.4B
Net Income$67.0B↓25%$89.0B↓8%$96.2B↑523%-$22.8B↓125%$89.9B
EPS (Diluted)----------
Gross Margin—————
Operating Margin14.3%↓5%15.0%↑26%11.9%↑1%11.8%11.7%
ROE9.3%↓32%13.7%↓20%17.1%↑457%-4.8%↓127%17.8%
Total Debt----------
Shareholders' Equity$717.4B↑10%$649.4B↑16%$561.3B↑19%$473.4B↓6%$506.2B
Current Ratio—————
Debt / Equity—————
Operating Cash Flow$46.0B↑50%$30.6B↓38%$49.2B↑32%$37.4B↓5%$39.4B
Free Cash Flow$25.0B↑116%$11.6B↓61%$29.8B↑36%$21.9B↓16%$26.2B
Scored from 10-K1d ago
MetricMarks

Risk-Aware Value

Akre

Three-Legged Stool

Druckenmiller

Macro-Enhanced Growth

Spier

Value Checklist

Pabrai

Dhandho Framework

Munger

Quality Focus

Ackman

Activist Value

Piotroski

F-Score

Greenblatt

Magic Formula

Lynch

GARP

Buffett

Quality Compounder

Graham

Defensive Value

VerdictHOLDFAILPASSBUYHOLDPASSFAILFAILNot rankedFAILFAILFAIL
Score
Analysis
Intrinsic ValueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Margin of SafetyN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Data As Of10-K (2026-08-15)10-K (2026-08-15)10-K (2026-08-15)10-K (2026-08-15)10-K (2026-08-15)10-K (2026-08-15)10-K (2026-08-15)10-K (2026-08-15)10-K (2026-08-15)10-K (2026-08-15)10-K (2026-08-15)10-K (2026-08-15)

Where They Agree

  • Efficiency

    All 6 investors flag BRK-A's efficiency

    ROIC (high and growing)
    ✗AkreROIC > 15% for 3+ years
    Reinvestment Rate x ROIC
    ✗AkreReinvestment Rate * ROIC > 10%
    Return on Invested Capital
    ✗Munger> 15%
    Current Ratio Change YoY
    ✗PiotroskiIncreased YoY
    Show 5 more metrics ▾
    Revenue / Total Assets Change YoY0.32x -> 0.30x
    ✗PiotroskiImproved YoY
    EBIT / (NWC + Net Fixed Assets)
    ✗Greenblatt> 25%
    ROIC (3-5 yr avg)
    ✗Buffett> 10%
    ROIC - WACC
    ✗BuffettPositive (WACC = 10%)
    Current Ratio
    ✗Graham>= 2.0

Where They Disagree

  • Profitability

    No clean pass — all 11 investors flag at least one profitability criterion

    Discount to Intrinsic Value
    ✗Marks>= 20% below intrinsic value
    Positive Net Income Frequency27/28 years positive
    ✓MarksPositive net income in >= 7 of last 10 years
    Return on Equity13.4% (3-yr avg)
    ✗AkreROE > 20% (3-year avg)
    EPS Growth Acceleration
    ✗DruckenmillerAccelerating EPS growth
    Show 19 more metrics ▾
    Margin of Safety
    ✗SpierP/E < 15 AND P/B < 2.0✗PabraiP/B < 1.5 or P/E < 15
    Operating Income / Revenue14.3%
    ✗Ackman>= 15%
    Net Income / Shareholders Equity9.3%
    ✗Ackman>= 15%
    Net Income / Total Assets5.48%
    ✓PiotroskiROA > 0
    ROA Change YoY7.71% -> 5.48% (delta: -2.23%)
    ✗PiotroskiCurrent ROA > Prior ROA
    (CFO / Total Assets) vs ROACFO/Assets=3.76%, ROA=5.48%
    ✗PiotroskiCFO/Assets > ROA
    Gross Margin Change YoY
    ✗PiotroskiImproved YoY
    EBIT / Enterprise Value
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=None, ROC=None
    ✗GreenblattBoth EY > 10% and ROC > 25%
    3-5 Year EPS CAGR25.1%
    ✓Lynch15-30% (Fast Grower); > 0% to pass
    ROE9.3%
    ✗Lynch> 15%
    Net Income Positive (10+ years)27/28 years positive
    ✗BuffettPositive every year for 10+ years
    ROE (5-yr avg)10.6%
    ✗Buffett> 15% (5-yr avg)
    Operating Margin (10-yr trend)14.3% (latest)
    ✗BuffettStable or rising over 10 years
    Free Cash Flow Proxy$67.0B
    ✓BuffettPositive and growing
    Earnings Variance (10-yr CoV)0.63
    ✗BuffettCoV < 0.3
    Retained Earnings Effectiveness
    ✗Buffett$1 retained -> > $1 market value created
    Positive EPS (10 years)10/28 years positive
    ✗GrahamPositive EPS every year for 10 years
    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
  • Debt & Leverage

    1 of 8 pass — Marks, Akre, Munger +4 more object

    Interest Coverage & Debt/EBITDAIC=10.4x, D/EBITDA=N/A
    ✗MarksInterest Coverage > 3x; Debt/EBITDA < 4x
    Debt Levels
    ✗AkreDebt/Equity < 0.3✗MungerDebt/Equity < 0.5
    Total Debt / Shareholders Equity
    ✗Ackman<= 1.0
    LT Debt / Total Assets Change0.00% -> 0.00%
    ✓PiotroskiDecreased YoY
    Show 4 more metrics ▾
    Total Debt / Equity
    ✗Lynch< 0.33
    Cash - Long-term Debt
    ✗LynchPositive preferred
    Debt/Equity & Interest Coverage
    ✗BuffettD/E < 0.5 AND Interest Coverage > 5x
    LT Debt vs Net Current Assets
    ✗GrahamLT Debt <= Net Current Assets
  • Valuation

    1 of 9 pass — Marks, Spier, Pabrai +5 more object

    P/B or P/E vs. Historical Average
    ✗MarksP/E < 15 or P/B < 2.0
    Discount to Intrinsic Value
    ✗Marks>= 20% below intrinsic value
    Price vs. 200-day MAQualitative
    ✓DruckenmillerPrice above 200-day moving average
    Margin of Safety
    ✗SpierP/E < 15 AND P/B < 2.0
    Show 9 more metrics ▾
    P/E or FCF Yield
    ✗PabraiP/E < 15 or FCF Yield > 10%
    Valuation Reasonableness
    ✗MungerP/E < 25 or Owner Earnings Yield > 5%
    Price / FCF per Share
    ✗Ackman<= 25
    EBIT / Enterprise Value
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=None, ROC=None
    ✗GreenblattBoth EY > 10% and ROC > 25%
    P/E / EPS Growth Rate
    ✗Lynch< 1.0 (ideally < 0.5)
    Price / 3-yr avg EPS
    ✗Graham<= 15x
    Price-to-Book Ratio
    ✗Graham<= 1.5x
    P/E x P/B
    ✗Graham<= 22.5
  • Cash Flow

    3 of 6 pass — Pabrai, Ackman and Piotroski object

    FCF Positive18/18 years FCF positive
    ✓MarksPositive FCF in majority of recent years
    P/E or FCF Yield
    ✗PabraiP/E < 15 or FCF Yield > 10%
    (OCF - CapEx) / Market Cap
    ✗Ackman>= 4%
    Price / FCF per Share
    ✗Ackman<= 25
    Show 4 more metrics ▾
    Operating Cash Flow$46.0B
    ✓PiotroskiCFO > 0
    (CFO / Total Assets) vs ROACFO/Assets=3.76%, ROA=5.48%
    ✗PiotroskiCFO/Assets > ROA
    FCF Positive and Growing$25.0B
    ✓LynchPositive and growing
    Free Cash Flow Proxy$67.0B
    ✓BuffettPositive and growing
  • Growth

    1 of 5 pass — Druckenmiller, Ackman, Lynch +1 more object

    Positive Net Income Frequency27/28 years positive
    ✓MarksPositive net income in >= 7 of last 10 years
    EPS Growth Acceleration
    ✗DruckenmillerAccelerating EPS growth
    Revenue Growth RateLatest: 0.0%, Prior: 1.9%
    ✗DruckenmillerRevenue growth accelerating
    3yr Median Revenue Growth1.9%
    ✗Ackman>= 5%
    Show 5 more metrics ▾
    Positive EPS Growth Frequency
    ✗AckmanPositive EPS growth in >= 3 of last 5 years
    P/E / EPS Growth Rate
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR25.1%
    ✓Lynch15-30% (Fast Grower); > 0% to pass
    Inventory Growth vs Revenue GrowthInv: 1.7% vs Rev: 0.0%
    ✗LynchInventory growth < Revenue growth
    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
  • Verdicts

    Split decision: 6 FAIL · 2 HOLD · 2 PASS · 1 BUY

    Overall verdict
    •MarksHOLD (5/8)✗AkreFAIL (2/7)✓DruckenmillerPASS (4/7)✓SpierBUY (7/8)•PabraiHOLD (5/8)✓MungerPASS (4/7)✗AckmanFAIL (1/9)✗PiotroskiFAIL (F-Score 3)•GreenblattNot ranked✗LynchFAIL (2/7)✗BuffettFAIL (1/9)✗GrahamFAIL (1/9)

Historical Score Timeline

Industry Peers

Similar companies in Insurance

BRK-B vs Peers — Financial Grading

Revenue$371.4BTop 25%
Net Income$67.0BTop 25%
ROE9.3%Bottom 25%
D/E—
Op. Margin14.3%Top 25%
Curr. Ratio—
CompanyMarket CapPriceRevenueNet IncomeROED/EOp. MarginCurr. RatioGrahamBuffettLynchGreenblattPiotroski
UNITEDHEALTH GROUP INCUNH$360.6B$401.73$447.6B$12.1B12.0%0.784.2%0.793/96/91/70/3F-Score 7
PROGRESSIVE CORP/OH/PGR$121.9B$209.60$87.7B$11.3B37.3%0.00——3/93/96/70/3F-Score 6
Elevance Health, Inc.ELV$86.8B$400.32$199.1B$5.7B12.9%0.753.6%1.545/95/92/71/3F-Score 6
Cigna GroupCI$74.7B$282.56$274.9B$6.0B14.3%0.013.3%0.851/94/93/71/3F-Score 8
AEGON LTD.AEFC$28.5B$18.36—$1.1B10.4%———0/91/91/70/3F-Score 5
PRINCIPAL FINANCIAL GROUP INCPFG$24.4B$113.98$15.6B$1.2B10.0%0.33——2/93/93/70/3F-Score 5
MARKEL GROUP INC.MKL$22.9B$1847.24$15.5B$2.1B11.3%0.2320.6%—4/96/95/71/3F-Score 5
Fidelity National Financial, Inc.FNF$13.3B$49.47$14.4B$602.0M8.1%0.59——2/92/92/70/3F-Score 5